Provided by Tiger Trade Technology Pte. Ltd.

Maravai LifeSciences Holdings, Inc.

3.14
+0.05001.62%
Post-market: 3.140.00000.00%18:20 EST
Volume:1.13M
Turnover:3.53M
Market Cap:802.92M
PE:-3.73
High:3.21
Open:3.17
Low:3.07
Close:3.09
52wk High:4.98
52wk Low:1.67
Shares:255.71M
Float Shares:92.75M
Volume Ratio:0.92
T/O Rate:1.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8429
EPS(LYR):-1.0503
ROE:-40.92%
ROA:-7.78%
PB:3.27
PE(LYR):-2.99

Loading ...

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Maravai Lifesciences Holdings (MRVI)

TIPRANKS
·
Jan 29

Director Gregory T. Lucier acquires common shares of Maravai LifeSciences Holdings Inc

Reuters
·
Dec 10, 2025

Maravai LifeSciences CEO Bernd Brust Reports Acquisition of Common Shares

Reuters
·
Nov 18, 2025

Stock Track | Maravai LifeSciences (MRVI) Soars 5.54% After Hours on CEO's Share Acquisition

Stock Track
·
Nov 14, 2025

Stock Track | Maravai LifeSciences (MRVI) Soars 5.54% After-Hours on CEO's Share Acquisition

Stock Track
·
Nov 14, 2025

CEO Bernd Brust Reports Acquisition of Maravai LifeSciences Holdings Inc. Common Shares

Reuters
·
Nov 14, 2025

Maravai LifeSciences CFO to Join Jefferies Healthcare Conference Fireside Chat

Reuters
·
Nov 10, 2025

Cautious Optimism for Maravai Lifesciences: Hold Rating Amidst Strategic Recovery Efforts

TIPRANKS
·
Nov 07, 2025

Stock Track | Maravai LifeSciences Plunges 7.27% Following Q3 Revenue Miss and Weak Guidance

Stock Track
·
Nov 07, 2025

Stock Track | Maravai LifeSciences Plunges 9.34% After Hours on Disappointing Q3 Results and Weak Guidance

Stock Track
·
Nov 07, 2025

Maravai LifeSciences Q3 revenue misses estimates on weakness in nucleic acid segment

Reuters
·
Nov 07, 2025

Maravai LifeSciences reports Q3 revenue of $41.6 million and net loss of $45.1 million

Reuters
·
Nov 07, 2025

Maravai LifeSciences Holdings Inc: Organizational Restructuring and Operating Cost Reduction Initiatives on Track

THOMSON REUTERS
·
Nov 07, 2025

Maravai LifeSciences Holdings Inc expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
Nov 05, 2025

Craig-Hallum Keeps Their Buy Rating on Maravai Lifesciences Holdings (MRVI)

TIPRANKS
·
Nov 04, 2025

Maravai LifeSciences Reduces Board Size and Appoints New Committee Members

Reuters
·
Oct 28, 2025

Maravai LifeSciences Holdings Inc. to Release Third Quarter 2025 Results

Reuters
·
Oct 23, 2025

Avantor Inc. Appoints Gregory T. Lucier to Board of Directors, Strengthening Leadership Team

Reuters
·
Oct 03, 2025

Deutsche Bank Adjusts Maravai Lifesciences Price Target to $4.50 From $5, Maintains Buy Rating

MT Newswires Live
·
Aug 12, 2025

Maravai Life Sciences Cuts 25% of Workforce

Dow Jones
·
Aug 12, 2025